TCL Archive Bristol-Myers Squibb Co. has agreed to pay $450 million to settle class action suits from shareholders and separate civil claims by the Securities and Exchange Commission. The settlements stem from Bristol’s practice of building up wholesalers’ inventories and diverting operating income to enhance dividends. August 6, 2004
TCL Archive Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs January 28, 2005
TCL Archive Cancer Policy: NCAB Recommends Mammograms Every 1 to 2 Years for Average Risk Women 40-49 April 4, 1997
TCL Archive Darbepoetin Didn’t Decrease Blood Transfusions, Lowered Overall Survival, Study Finds April 27, 2007
